122 related articles for article (PubMed ID: 35819483)
1. Postponed care due to COVID-19 lockdown impact on visual acuity of retinal vein occlusion patients: a large cohort.
Cohen R; Shor R; Segal O; Greenbaum E; Ayalon A; Trivizki O; Schwartz S; Loewenstein A; Rabina G
Graefes Arch Clin Exp Ophthalmol; 2023 Jan; 261(1):43-48. PubMed ID: 35819483
[TBL] [Abstract][Full Text] [Related]
2. COVID-19 Pandemic Lockdowns' Impact on Visual Acuity of Diabetic Macular Edema: A Large Cohort.
Gomel N; Shor R; Lippin N; Segal O; Greenbaum E; Schwartz S; Trivizki O; Loewenstein A; Rabina G
Ophthalmologica; 2023; 246(1):1-8. PubMed ID: 36380651
[TBL] [Abstract][Full Text] [Related]
3. Delayed anti-VEGF injections during the COVID-19 pandemic and changes in visual acuity in patients with three common retinal diseases: A systematic review and meta-analysis.
Im JHB; Jin YP; Chow R; Dharia RS; Yan P
Surv Ophthalmol; 2022; 67(6):1593-1602. PubMed ID: 35970234
[TBL] [Abstract][Full Text] [Related]
4. Treatment patterns and visual acuity change of AMD patients, before, during and after the COVID-19 pandemic lockdowns: A large cohort.
Barequet D; Shor R; Segal O; Greenbaum E; Trivizki O; Loewenstein A; Rabina G
Acta Ophthalmol; 2024 May; 102(3):e322-e327. PubMed ID: 37698269
[TBL] [Abstract][Full Text] [Related]
5. IMPACT OF COVID-19 PANDEMIC LOCKDOWNS ON VISUAL ACUITY OF PATIENTS WITH NEOVASCULAR AMD: A Large Cohort.
Shor R; Segal O; Mimouni M; Greenbaum E; Zur D; Trivizki O; Schwartz S; Loewenstein A; Goldstein M; Rabina G
Retina; 2022 Aug; 42(8):1529-1535. PubMed ID: 35502974
[TBL] [Abstract][Full Text] [Related]
6. The prevalence of vitreomacular adhesion in eyes with macular oedema secondary to retinal vein occlusion selected for intravitreal injections.
Maggio E; Maraone G; Mete M; Vingolo EM; Grenga PL; Guerriero M; Pertile G
Acta Ophthalmol; 2021 Nov; 99(7):e1154-e1161. PubMed ID: 33421346
[TBL] [Abstract][Full Text] [Related]
7. The impact of delayed anti-vascular endothelial growth factor treatment for retinal diseases during the COVID-19 lockdown.
Bulut MN; Sönmez HS; Gökçe G; Ağaçkesen A; Bulut K; Hacısalihoğlu A; Arsan A; Şimşek Ş
Photodiagnosis Photodyn Ther; 2021 Sep; 35():102449. PubMed ID: 34314862
[TBL] [Abstract][Full Text] [Related]
8. The importance of monitoring wet age-related macular degeneration patients during Coronavirus disease 19 pandemic: A retrospective study of assessment of functional and structural outcomes.
Tsiropoulos GN; Vallee R; Gallo Castro D; Ambresin A
J Fr Ophtalmol; 2022 Oct; 45(8):852-859. PubMed ID: 35908993
[TBL] [Abstract][Full Text] [Related]
9. Treatment of Retinal Vein Occlusion with Ranibizumab in Clinical Practice: Longer-Term Results and Predictive Factors of Functional Outcome.
Farinha C; Marques JP; Almeida E; Baltar A; Santos AR; Melo P; Costa M; Figueira J; Cachulo ML; Pires I; Silva R
Ophthalmic Res; 2015; 55(1):10-8. PubMed ID: 26540281
[TBL] [Abstract][Full Text] [Related]
10. Spectral-Domain OCT Predictors of Visual Outcomes after Ranibizumab Treatment for Macular Edema Resulting from Retinal Vein Occlusion.
Yiu G; Welch RJ; Wang Y; Wang Z; Wang PW; Haskova Z
Ophthalmol Retina; 2020 Jan; 4(1):67-76. PubMed ID: 31669329
[TBL] [Abstract][Full Text] [Related]
11. RETINAL VEIN OCCLUSIONS BEFORE AND DURING THE COVID-19 PANDEMIC: Visual Outcomes and Treatment Patterns in a Country with no Mandatory Lockdown.
Cullhed Farrell A; Epstein D
Retina; 2024 Jun; 44(6):1045-1051. PubMed ID: 38346093
[TBL] [Abstract][Full Text] [Related]
12. Visual and Anatomic Outcomes following Cataract Surgery in Patients with Pre-operative Macular Edema Due to Retinal Vein Occlusions Managed with Intravitreal anti-VEGF.
Starr MR; Mahr MA; Iezzi R; Barkmeier AJ; Bakri SJ
Semin Ophthalmol; 2020 May; 35(4):205-209. PubMed ID: 32721186
[TBL] [Abstract][Full Text] [Related]
13. Sub-optimal gain in vision in retinal vein occlusion due to under-treatment in the real world: results from an open-label prospective study of Intravitreal Ranibizumab.
Narayanan R; Kelkar A; Abbas Z; Goel N; Soman M; Naik N; Sudhalkar A; Walinjkar J; Shah U; Maksane N
BMC Ophthalmol; 2021 Jan; 21(1):33. PubMed ID: 33435908
[TBL] [Abstract][Full Text] [Related]
14. Ranibizumab for macular edema due to retinal vein occlusions: long-term follow-up in the HORIZON trial.
Heier JS; Campochiaro PA; Yau L; Li Z; Saroj N; Rubio RG; Lai P
Ophthalmology; 2012 Apr; 119(4):802-9. PubMed ID: 22301066
[TBL] [Abstract][Full Text] [Related]
15. The Role of Serum Inflammation-Based Factors in Anti-Vascular Endothelial Growth Factor Treatment for Macular Edema Secondary to Retinal Vein Occlusion and Its Subtypes.
Rao J; Wu N; Qu X; Hu Y; Wu Y; Cheng Y; Yan L; Huang H; Li S; Shi L; Wu X
Ophthalmic Res; 2021; 64(2):237-245. PubMed ID: 32506058
[TBL] [Abstract][Full Text] [Related]
16. Ranibizumab Pro Re nata versus Dexamethasone in the Management of Ischemic Retinal Vein Occlusion:
Pielen A; Feltgen N; Hattenbach LO; Hoerauf H; Bertelmann T; Quiering C; Vögeler J; Priglinger S; Lang GE; Schmitz-Valckenberg S; Wolf A; Rehak M
Curr Eye Res; 2020 May; 45(5):604-614. PubMed ID: 31665935
[No Abstract] [Full Text] [Related]
17. Outcomes in Retinal Vein Occlusions Presenting with Poor Visual Acuity Treated with Anti-Vascular Endothelial Growth Factor Therapy: Prognosis and Predictive Factors.
Light JG; Tian J; Wenick AS
Ophthalmol Retina; 2021 Sep; 5(9):888-900. PubMed ID: 33227561
[TBL] [Abstract][Full Text] [Related]
18. Intravitreal ranibizumab for macular edema secondary to retinal vein occlusion.
Kim M; Yu SY; Kim ES; Bae SH; Park JH; Yu HG; Kwak HW
Ophthalmologica; 2012; 227(3):132-8. PubMed ID: 22212151
[TBL] [Abstract][Full Text] [Related]
19. Changes in Retinal Microvasculature and Visual Acuity After Antivascular Endothelial Growth Factor Therapy in Retinal Vein Occlusion.
Winegarner A; Wakabayashi T; Fukushima Y; Sato T; Hara-Ueno C; Busch C; Nishiyama I; Shiraki N; Sayanagi K; Nishida K; Sakaguchi H; Nishida K
Invest Ophthalmol Vis Sci; 2018 Jun; 59(7):2708-2716. PubMed ID: 29860457
[TBL] [Abstract][Full Text] [Related]
20. Retinal oximetry during treatment of retinal vein occlusion by ranibizumab in patients with high blood pressure and dyslipidemia.
Keilani C; Halalchi A; Wakpi Djeugue D; Regis A; Abada S
J Fr Ophtalmol; 2016 Dec; 39(10):816-821. PubMed ID: 27865689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
